BridgeMD
New treatment option for Prostate Cancer
Official title Preop Laxatives in Robotic Urologic Surgery
ClinicalTrials.gov ID: NCT05805436
What this study is testing
What is Polyethylene Glycol 3350?
Polyethylene Glycol 3350 is an investigational medicine, being studied as a potential treatment for prostate cancer.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Minimally-invasive surgery, either laparoscopic or robotic, is commonly used in urology. Several urologic procedures including prostatectomy, radical nephrectomy, and partial nephrectomy are now commonly performed robotically.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 30 to 100. Healthy volunteers may be eligible.
You may be able to join if
- -Patients 30 years or older undergoing robotic-assisted laparoscopic radical prostatectomy, transperitoneal radical nephrectomy, or transperitoneal...
You likely can't join if
- Patients under 30 years old
- Patients with a contraindication to receiving polyethylene glycol or other forms of laxatives
- People who regularly take Miralax
- Patients undergoing retroperitoneal radical or partial nephrectomy
- Patients with severe ulcerative colitis or Crohn's disease
- Patients with intestinal diversions (colostomy, ileostomy)
See the full eligibility criteria
- -Patients 30 years or older undergoing robotic-assisted laparoscopic radical prostatectomy, transperitoneal radical nephrectomy, or transperitoneal partial nephrectomy
- Patients under 30 years old
- Patients with a contraindication to receiving polyethylene glycol or other forms of laxatives
- People who regularly take Miralax
- Patients undergoing retroperitoneal radical or partial nephrectomy
- Patients with severe ulcerative colitis or Crohn's disease
- Patients with intestinal diversions (colostomy, ileostomy)
- Patients with prior abdominal or pelvic radiation
- Patients who will not follow up with UIHC postoperatively
- Patients who are incarcerated
The study team makes the final eligibility decision.
Where it's taking place
- Iowa City, Iowa, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 30 years to 100 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Iowa City, Iowa, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.